B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets von Yoshizaki, Ayumi

Volltext

Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis von Kuzumi, Ai, Yoshizaki, Ayumi, Matsuda, Kazuki M., Kotani, Hirohito, Norimatsu, Yuta, Fukayama, Maiko, Ebata, Satoshi, Fukasawa, Takemichi, Yoshizaki-Ogawa, Asako, Asano, Yoshihide, Morikawa, Kyojiro, Kazoe, Yutaka, Mawatari, Kazuma, Kitamori, Takehiko, Sato, Shinichi

Volltext

IL-10-producing regulatory B cells (B10 cells) in autoimmune disease von Kalampokis, Ioannis, Yoshizaki, Ayumi, Tedder, Thomas F

Volltext

Single-cell-level protein analysis revealing the roles of autoantigen-reactive B lymphocytes in autoimmune disease and the murine model von Fukasawa, Takemichi, Yoshizaki, Ayumi, Ebata, Satoshi, Yoshizaki-Ogawa, Asako, Asano, Yoshihide, Enomoto, Atsushi, Miyagawa, Kiyoshi, Kazoe, Yutaka, Mawatari, Kazuma, Kitamori, Takehiko, Sato, Shinichi

Volltext

Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma von Takahashi, Takehiro, Asano, Yoshihide, Sugawara, Koji, Yamashita, Takashi, Nakamura, Kouki, Saigusa, Ryosuke, Ichimura, Yohei, Toyama, Tetsuo, Taniguchi, Takashi, Akamata, Kaname, Noda, Shinji, Yoshizaki, Ayumi, Tsuruta, Daisuke, Trojanowska, Maria, Sato, Shinichi

Volltext

Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti‐melanoma differentiation‐associated gene 5 antibody‐posit... von Matsuda, Kazuki M., Yoshizaki, Ayumi, Kuzumi, Ai, Fukasawa, Takemichi, Ebata, Satoshi, Yoshizaki‐Ogawa, Asako, Sato, Shinichi

Volltext

Cytokine analysis on a countable number of molecules from living single cells on nanofluidic devices von Nakao, Tatsuro, Kazoe, Yutaka, Mori, Emi, Morikawa, Kyojiro, Fukasawa, Takemichi, Yoshizaki, Ayumi, Kitamori, Takehiko

Volltext

B Cell Depletion Inhibits Fibrosis via Suppression of Profibrotic Macrophage Differentiation in a Mouse Model of Systemic Sclerosis von Numajiri, Hiroko, Kuzumi, Ai, Fukasawa, Takemichi, Ebata, Satoshi, Yoshizaki‐Ogawa, Asako, Asano, Yoshihide, Kazoe, Yutaka, Mawatari, Kazuma, Kitamori, Takehiko, Yoshizaki, Ayumi, Sato, Shinichi

Volltext

Involvement of Molecular Mechanisms between T/B Cells and IL-23: From Palmoplantar Pustulosis to Autoimmune Diseases von Fukasawa, Takemichi, Yoshizaki-Ogawa, Asako, Enomoto, Atsushi, Miyagawa, Kiyoshi, Sato, Shinichi, Yoshizaki, Ayumi

Volltext

Pharmacotherapy of Itch—Antihistamines and Histamine Receptors as G Protein-Coupled Receptors von Fukasawa, Takemichi, Yoshizaki-Ogawa, Asako, Enomoto, Atsushi, Miyagawa, Kiyoshi, Sato, Shinichi, Yoshizaki, Ayumi

Volltext

Predictors of Rituximab Effect on Modified Rodnan Skin Score in Systemic Sclerosis: a machine learning analysis of the DESIRES trial von Ebata, Satoshi, Oba, Koji, Kashiwabara, Kosuke, Ueda, Keiko, Uemura, Yukari, Watadani, Takeyuki, Fukasawa, Takemichi, Miura, Shunsuke, Yoshizaki-Ogawa, Asako, Yoshihide, Asano, Yoshizaki, Ayumi, Sato, Shinichi

Volltext

Apremilast Decreased Proinflammatory Cytokines and Subsequently Increased Inhibitory ones in Psoriasis: A Prospective Cohort Study von Fukasawa, Takemichi, Yoshizaki-Ogawa, Asako, Enomoto, Atsushi, Sato, Shinichi, Yoshizaki, Ayumi

Volltext

Utility of nailfold capillary assessment for predicting psoriatic arthritis based on a prospective observational cohort study von Fukasawa, Takemichi, Toyama, Satoshi, Enomoto, Atsushi, Yoshizaki-Ogawa, Asako, Norimatsu, Yuta, Tateishi, Shoko, Kanda, Hiroko, Miyagawa, Kiyoshi, Sato, Shinichi, Yoshizaki, Ayumi

Volltext

Increased Serum Levels of Tumor Necrosis Factor-like Ligand 1A in Atopic Dermatitis von Hisamoto, Teruyoshi, Suga, Hiraku, Yoshizaki-Ogawa, Asako, Sato, Shinichi, Yoshizaki, Ayumi

Volltext

Percentage of residual B cells after 2 weeks of rituximab treatment predicts the improvement of systemic sclerosis‐associated interstitial lung disease von Ebata, Satoshi, Yoshizaki, Ayumi, Fukasawa, Takemichi, Yoshizaki‐Ogawa, Asako, Asano, Yoshihide, Kashiwabara, Kosuke, Oba, Koji, Sato, Shinichi

Volltext

New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics von Ebata, Satoshi, Yoshizaki-Ogawa, Asako, Sato, Shinichi, Yoshizaki, Ayumi

Volltext

Interleukin (IL)‐17F and IL‐17E are related to fibrosis and vasculopathy in systemic sclerosis von Fukayama, Maiko, Yoshizaki, Ayumi, Fukasawa, Takemichi, Ebata, Satoshi, Kuzumi, Ai, Yoshizaki‐Ogawa, Asako, Asano, Yoshihide, Oba, Koji, Sato, Shinichi

Volltext

Involvement of B cells in the development of systemic sclerosis von Yoshizaki, Ayumi, Fukasawa, Takemichi, Ebata, Satoshi, Yoshizaki-Ogawa, Asako, Sato, Shinichi

Volltext

Decrease in MAP3Ks expression enhances the cell death caused by hyperthermia von Enomoto, Atsushi, Fukasawa, Takemichi, Terunuma, Hiroshi, Nakagawa, Keiichi, Yoshizaki, Ayumi, Sato, Shinichi, Miyagawa, Kiyoshi

Volltext

Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis von Fukasawa, Takemichi, Yoshizaki, Ayumi, Ebata, Satoshi, Nakamura, Kouki, Saigusa, Ryosuke, Miura, Syunsuke, Yamashita, Takashi, Hirabayashi, Megumi, Ichimura, Yohei, Taniguchi, Takashi, Asano, Yoshihide, Shimizu, Hisashi, Kazoe, Yutaka, Mawatari, Kazuma, Kitamori, Takehiko, Sato, Shinichi

Volltext